Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Antipsychotic drugs and obesity.

Correll CU, Lencz T, Malhotra AK.

Trends Mol Med. 2011 Feb;17(2):97-107. doi: 10.1016/j.molmed.2010.10.010. Epub 2010 Dec 22. Review.

2.

Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.

Lett TA, Wallace TJ, Chowdhury NI, Tiwari AK, Kennedy JL, Müller DJ.

Mol Psychiatry. 2012 Mar;17(3):242-66. doi: 10.1038/mp.2011.109. Epub 2011 Sep 6. Review.

PMID:
21894153
3.

Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain.

Malhotra AK, Correll CU, Chowdhury NI, Müller DJ, Gregersen PK, Lee AT, Tiwari AK, Kane JM, Fleischhacker WW, Kahn RS, Ophoff RA, Meltzer HY, Lencz T, Kennedy JL.

Arch Gen Psychiatry. 2012 Sep;69(9):904-12.

4.

Pharmacogenetics of antipsychotic-induced weight gain.

Correll CU, Malhotra AK.

Psychopharmacology (Berl). 2004 Aug;174(4):477-89. Epub 2004 Jul 8. Review.

PMID:
15243737
5.

Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.

Gregoor JG, van der Weide J, Mulder H, Cohen D, van Megen HJ, Egberts AC, Heerdink ER.

J Clin Psychopharmacol. 2009 Feb;29(1):21-5. doi: 10.1097/JCP.0b013e31819359be.

PMID:
19142102
6.

Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications.

Lee AK, Bishop JR.

Pharmacogenomics. 2011 Jul;12(7):999-1016. doi: 10.2217/pgs.11.45. Review.

7.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. French.

PMID:
19748369
8.

Which comes first: atypical antipsychotic treatment or cardiometabolic risk?

Stahl SM, Mignon L, Meyer JM.

Acta Psychiatr Scand. 2009 Mar;119(3):171-9. doi: 10.1111/j.1600-0447.2008.01334.x. Review.

PMID:
19178394
9.

[Antipsychotic-induced weight gain--pharmacogenetic studies].

Olajossy-Hilkesberger L, Godlewska B, Marmurowska-Michałowskal H, Olajossy M, Landowski J.

Psychiatr Pol. 2006 Sep-Oct;40(5):1009-20. Review. Polish.

PMID:
17217242
10.

Management of antipsychotic-related weight gain.

Maayan L, Correll CU.

Expert Rev Neurother. 2010 Jul;10(7):1175-200. doi: 10.1586/ern.10.85. Review.

11.

Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin.

Jin H, Meyer JM, Mudaliar S, Jeste DV.

Schizophr Res. 2008 Mar;100(1-3):70-85. doi: 10.1016/j.schres.2007.11.026. Epub 2008 Jan 18. Review.

12.
13.

Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.

Basile VS, Masellis M, McIntyre RS, Meltzer HY, Lieberman JA, Kennedy JL.

J Clin Psychiatry. 2001;62 Suppl 23:45-66. Review.

14.

Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting.

Gregoor JG, van der Weide J, Loovers HM, van Megen HJ, Egberts TC, Heerdink ER.

Pharmacogenomics. 2011 Jun;12(6):919-23. doi: 10.2217/pgs.11.40. Epub 2011 Apr 21.

PMID:
21510767
15.

Metabolic consequences of antipsychotic therapy: preclinical and clinical perspectives on diabetes, diabetic ketoacidosis, and obesity.

Heal DJ, Gosden J, Jackson HC, Cheetham SC, Smith SL.

Handb Exp Pharmacol. 2012;(212):135-64. doi: 10.1007/978-3-642-25761-2_6. Review.

PMID:
23129331
16.

Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?

Le Hellard S, Theisen FM, Haberhausen M, Raeder MB, Fernø J, Gebhardt S, Hinney A, Remschmidt H, Krieg JC, Mehler-Wex C, Nöthen MM, Hebebrand J, Steen VM.

Mol Psychiatry. 2009 Mar;14(3):308-17. doi: 10.1038/sj.mp.4002133. Epub 2008 Jan 15.

PMID:
18195716
17.

Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms.

Reynolds GP, Kirk SL.

Pharmacol Ther. 2010 Jan;125(1):169-79. doi: 10.1016/j.pharmthera.2009.10.010. Epub 2009 Nov 17. Review.

PMID:
19931306
18.

Association study of serotonergic gene variants with antipsychotic-induced adverse reactions.

Al-Janabi I, Arranz MJ, Blakemore AI, Saiz PA, Susce MT, Glaser PE, Clark D, de Leon J.

Psychiatr Genet. 2009 Dec;19(6):305-11. doi: 10.1097/YPG.0b013e3283328dcd.

PMID:
19829168
19.

Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.

Nasrallah HA.

Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. Review.

PMID:
17848919
20.

Combined HTR2C-LEP genotype as a determinant of obesity in patients using antipsychotic medication.

Gregoor JG, Mulder H, Cohen D, van Megen HJ, Egberts TC, Heerdink ER, van der Weide J.

J Clin Psychopharmacol. 2010 Dec;30(6):702-5.

PMID:
21105285

Supplemental Content

Support Center